Doctor, doctor, give me the news, Hims & Hers Health ... an older GLP-1 weight-loss drug the company will add to its ...

Kathryn Thomas says she first realised that something was different about the popularity of GLP-1 medications like Ozempic and Mounjaro last year. A friend of hers, who is a doctor in the Middle ...

The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents. The knockoff surge was led by Hims & Hers Health, the telehealth firm ...

Telehealth company Hims & Hers Health (HIMS ... the active ingredient in Novo Nordisk’s (NVO) GLP-1 blockbuster weight loss medications Ozempic and Wegovy, when the branded treatments were ...

Drugs like Ozempic have a positive impact on weight loss, though only for a short period, with long-term health implications of a growing concern, the business said. GLP-1 drugs can also erode muscle ...

aren't the best options to achieve your weight loss goals. So, what is the No. 1 snack for weight loss? The answer is hummus. In a 2020 study in The Journal of Nutrition, people who ate an ...

Every item on this page was chosen by an ELLE editor. We may earn commission on some of the items you choose to buy. Introducing Hot Shots, a series that examines how Ozempic and other GLP-1 drugs ...

Semaglutide (GLP-1) weight-loss drug Wegovy, made by pharmaceutical company Novo Nordisk is seen on Oct. 16, 2024. James Manning/PA Images via Getty Images, FILE Narula said people currently ...

Novo Nordisk (NVO) plans to run studies on how its GLP-1 class of weight loss/diabetes drug can help people deal with addiction, Martin Holst Lange, the Danish pharma’s head of development ...

Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's weight-loss drug, as it widens its offerings ...